Literature DB >> 19128275

Using diuretics in practice--one opinion.

William J Elliott1, Richard H Grimm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19128275      PMCID： PMC8673062          DOI： 10.1111/j.1751-7176.2008.00029.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  52 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  A COMPARISON OF THE ANTIHYPERTENSIVE EFFECT OF CHLORTHALIDONE AND HYDROCHLORTHIAZIDE.

Authors:  W E BOWLUS; H G LANGFORD
Journal:  Clin Pharmacol Ther       Date:  1964 Nov-Dec       Impact factor: 6.875

Review 3.  Clinical practice. Resistant or difficult-to-control hypertension.

Authors:  Marvin Moser; John F Setaro
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

4.  Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

Authors:  Michael E Ernst; Barry L Carter; Chris J Goerdt; Jennifer J G Steffensmeier; Beth Bryles Phillips; M Bridget Zimmerman; George R Bergus
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Double-blind comparison of hydrochlorothiazide plus triameterene therapy versus chlorthalidone therapy in hypertension.

Authors:  E C Clark; S Podolsky; E J Thompson
Journal:  South Med J       Date:  1979-07       Impact factor: 0.954

7.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Authors:  Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

8.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael Farber; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carol Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Arch Intern Med       Date:  2005-04-25

9.  Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.

Authors:  H Knauf; E Mutschler
Journal:  J Cardiovasc Pharmacol       Date:  1995-09       Impact factor: 3.105

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272
View more
  4 in total

1.  The Last Nail in Hydrochlorothiazide's Coffin?

Authors:  Firas J Al Badarin; Carl J Lavie; James H O'Keefe
Journal:  Ochsner J       Date:  2012

Review 2.  Which diuretic is the preferred agent for treating essential hypertension: hydrochlorothiazide or chlorthalidone?

Authors:  F Wilford Germino
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

3.  Renewed interest in chlorthalidone: evidence from the Veterans Health Administration.

Authors:  Michael E Ernst; Brian C Lund
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08-30       Impact factor: 3.738

4.  All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.

Authors:  Michael E Ernst; Barry L Carter; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-01       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.